Effect of regular intravenous immunoglobulin therapy on prognosis of severe pneumonia in patients with COVID-19

被引:183
作者
Xie, Yun [1 ]
Cao, Song [2 ]
Dong, Hui [2 ]
Li, Qingyun [3 ]
Chen, Erzhen [4 ]
Zhang, Wenkai [2 ]
Yang, Luyu [2 ]
Fu, Shouzhi [2 ]
Wang, Ruilan [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Crit Care Med, 650 New Songjiang Rd, Shanghai 201600, Peoples R China
[2] Wuhan Univ, Wuhan Third Hosp, Dept Crit Care Med, 216 Guanshan Ave, Wuhan 430070, Hubei, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Dept Resp, Sch Med, 197 Ruijin Two Rd, Shanghai 200020, Peoples R China
[4] Shanghai Jiao Tong Univ, Shanghai Ruijin Hosp, Sch Med, 197 Ruijin Two Rd, Shanghai 200020, Peoples R China
关键词
D O I
10.1016/j.jinf.2020.03.044
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:340 / 343
页数:4
相关论文
共 10 条
  • [1] Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency
    Busse, PJ
    Razvi, S
    Cunningham-Rundles, C
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (06) : 1001 - 1004
  • [2] Immunoglobulin A modulates inflammatory responses in an in vitro model of pneumonia
    Diebel, LN
    Liberati, DM
    Diglio, CA
    Brown, WJ
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (05): : 1099 - 1106
  • [3] Coronavirus 2019-nCoV: A brief perspective from the front line
    Han, Qingmei
    Lin, Qingqing
    Jin, Shenhe
    You, Liangshun
    [J]. JOURNAL OF INFECTION, 2020, 80 (04) : 373 - 377
  • [4] Hyperimmune IV Immunoglobulin Treatment A Multicenter Double-Blind Randomized Controlled Trial for Patients With Severe 2009 Influenza A(H1N1) Infection
    Hung, Ivan F. N.
    To, Kelvin K. W.
    Lee, Cheuk-Kwong
    Lee, Kar-Lung
    Yan, Wing-Wa
    Chan, Kenny
    Chan, Wai-Ming
    Ngai, Chun-Wai
    Law, Kin-Ip
    Chow, Fu-Loi
    Liu, Raymond
    Lai, Kang-Yiu
    Lau, Candy C. Y.
    Liu, Shao-Haei
    Chan, Kwok-Hung
    Lin, Che-Kit
    Yuen, Kwok-Yung
    [J]. CHEST, 2013, 144 (02) : 464 - 473
  • [5] Current treatment options and the role of peptides as potential therapeutic components for Middle East Respiratory Syndrome(MERS): A review
    Mustafa, Sabeena
    Balkhy, Hanan
    Gabere, Musa N.
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2018, 11 (01) : 9 - 17
  • [6] Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
    Rockman, Steven
    Lowther, Sue
    Camuglia, Sarina
    Vandenberg, Kirsten
    Taylor, Shirley
    Fabri, Lou
    Miescher, Sylvia
    Pearse, Martin
    Middleton, Deborah
    Kent, Stephen J.
    Maher, Darry
    [J]. EBIOMEDICINE, 2017, 19 : 119 - 127
  • [7] SARS: Systematic review of treatment effects
    Stockman, Lauren J.
    Bellamy, Richard
    Garner, Paul
    [J]. PLOS MEDICINE, 2006, 3 (09) : 1525 - 1531
  • [8] Intravenous Immunoglobulin and Mortality in Pneumonia Patients With Septic Shock: An Observational Nationwide Study
    Tagami, Takashi
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    [J]. CLINICAL INFECTIOUS DISEASES, 2015, 61 (03) : 385 - 392
  • [9] Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
    Wang, Dawei
    Hu, Bo
    Hu, Chang
    Zhu, Fangfang
    Liu, Xing
    Zhang, Jing
    Wang, Binbin
    Xiang, Hui
    Cheng, Zhenshun
    Xiong, Yong
    Zhao, Yan
    Li, Yirong
    Wang, Xinghuan
    Peng, Zhiyong
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (11): : 1061 - 1069
  • [10] Yang Xiaobo, 2020, LANCET RESP MED, DOI [10.1016/S2213-260 0(20)30079-5, DOI 10.1016/S2213-2600(20)30079-5.]